Histopathologic follow‐up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital

BACKGROUND Cervical cancer screening in China is largely limited to occasional opportunistic screening in urban centers. The current study reports histopathologic follow‐up and human papillomavirus (HPV) results in women with high‐grade squamous intraepithelial lesion (HSIL) Papanicolaou (Pap) tests reported at the largest academic women's hospital in China and compares these findings with those of published Western studies among frequently screened women. METHODS A retrospective cohort study documented HSIL Pap tests, patient age, HPV results, and histopathologic follow‐up from 2011 through 2015 in the Obstetrics and Gynecology Hospital of Fudan University (OGHFU) in Shanghai, China. Of 886,122 Pap test results, 4269 (0.48%) reported HSIL. Histopathologic follow‐up was available for 2351 cases and HPV results were available for 2092 cases. RESULTS HSIL reporting rates increased with patient age from 0.16% at age